Data suggest gene, cell therapy trial initiations in Europe lag behind America — here's why
4BIO's Dmitry Kuzmin and Owen Smith enjoyed speaking to Natalie Grover at Endpoints on the state of cell & gene therapy trials in Europe and the US following yesterday’s report from the Alliance for Regenerative Medicine. We also discussed the trends 4BIO expects to see as more treatments are developed.
